Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.30
09.02.24
€0.000
09.02.25
-6.04%
19.02.24

buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.04
08.02.24
-
08.03.24
20.59%
09.03.24

buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.25
05.02.24
-
05.02.25
-10.95%
18.02.24

buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.35
05.02.24
-
05.02.25
29.34%
06.02.24

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
buy
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.10
05.02.24
€12.00
05.02.25
-36.38%
17.02.24

Coherus Bioscien.

Start price
Target price
Perf. (%)
€1.88
05.02.24
-
05.02.25
33.90%
17.02.24

Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.21
05.02.24
€6.00
05.02.25
-54.23%
16.03.24

buy
Syros Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.00
05.02.24
€20.00
05.02.25
-22.86%
16.03.24

Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.32
05.02.24
-
05.02.25
-43.81%
08.02.24

Good culture
Risky Investment
No uniques
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.35
05.02.24
-
05.02.25
-42.99%
08.02.24

buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.86
04.02.24
-
04.02.25
13.17%
04.03.24

buy
Carbylan Therapeutics Inc

Start price
Target price
Perf. (%)
€14.10
04.02.24
-
04.02.25
-2.84%
18.02.24

buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€1.87
04.02.24
-
04.02.25
34.90%
18.02.24

buy
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.25
04.02.24
€13.00
04.02.25
-44.24%
17.02.24

buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.40
04.02.24
€20.00
30.11.25
-77.89%
13.05.24

Could be very worthwhile Investment >20% year
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€0.98
04.02.24
€1.50
31.10.25
14.29%
29.04.24

Could be very worthwhile Investment >20% year
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.15
04.02.24
-
04.02.25
-6.51%
17.02.24

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€73.00
03.02.24
-
03.02.25
-2.74%
17.02.24

buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.84
03.02.24
-
03.02.25
20.87%
18.02.24

Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€8.85
03.02.24
€3.00
03.02.25
-13.05%
17.02.24

Twist Bioscience Corp

Start price
Target price
Perf. (%)
€33.40
03.02.24
€16.00
03.02.25
11.98%
17.02.24

XBiotech Inc

Start price
Target price
Perf. (%)
€5.10
03.02.24
€2.00
03.02.25
8.82%
17.02.24

Adverum Biotechnologies Inc.

Start price
Target price
Perf. (%)
€1.35
03.02.24
€1.00
03.02.25
42.22%
17.02.24

Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.25
03.02.24
€1.00
03.02.25
-44.24%
17.02.24

Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.05
02.02.24
-
02.02.25
19.45%
03.02.24